Drug Profile
Betamethasone/indometacin/methocarbamol
Alternative Names: Betamethasone/methocarbamol/indometacin; Indometacin/betamethasone/methocarbamol; Methocarbamol/indometacin/betamethasoneLatest Information Update: 14 Aug 2015
Price :
$50
*
At a glance
- Originator Iroko Pharmaceuticals
- Class Analgesics; Anti-inflammatories; Antiallergics; Antirheumatics; Corticosteroids; Fluorinated steroids; Indoles; Muscle relaxants; Nonsteroidal anti-inflammatories; Pregnadienetriols
- Mechanism of Action Cyclooxygenase inhibitors; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 14 Aug 2015 No recent reports on development identified - Phase-III for Pain in USA (unspecified route)
- 06 May 2011 Phase-III clinical trials in Pain in USA (unspecified route)